Fighting For Multiple Myeloma Patients in Desperate Need The Commitment From Johnson & Johnson’s Blood Cancer Leader

The U.S. President of Hematology at Johnson & Johnson understands the plight of multiple myeloma patients and the never-ending worry of relapse. So, he helps lead a team of experts focused on treatments to improve patients overall quality of life.